Latest News

Abbott's FreeStyle Libre system significantly reduces HbA1c levels in patients with type 2 diabetes

Abbott announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world's leading sensor-based glucose monitoring technology, is associated with significant reduction in hemoglobin A1c (HbA1c) levels for people living with type 2 diabetes on either long-acting insulin or non-insulin therapy.

Source link

Related posts

Scientists identify pathways that reveal insights into mechanism of lung cancer etiology


Atrophy can be combated by boosting expression of an enzyme produced in muscles


Why Are Doctors Removing Too Many Thyroids?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy